Evidence map›Paper›PMID 28123172›Full record

SynthesisMedical science monitor : international medical journal of experimental and clinical research2017

Knockdown of TCTN1 Strongly Decreases Growth of Human Colon Cancer Cells.

Xiaoyu Dai, Mingjun Dong, Hua Yu, Yangyang Xie, Yongming Yu, Yisheng Cao, Zhenfang Kong, Baofeng Zhou, Yidong Xu, Tong Yang and 1 more

Open access · hybridAbstract readMeta-Analysis
In one paragraph

Synthesis in Medical science monitor : international medical journal of experimental and clinical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Integrative cancer therapies
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Xiaoyu DaiDepartment of Anorectal Surgery, Ningbo Second Hospital, Ningbo, Zhejiang, China (mainland).
Mingjun DongDepartment of Anorectal Surgery, Ningbo Second Hospital, Ningbo, Zhejiang, China (mainland).
Hua YuDepartment of Anorectal Surgery, Ningbo Second Hospital, Ningbo, Zhejiang, China (mainland).
Yangyang XieDepartment of Anorectal Surgery, Ningbo Second Hospital, Ningbo, Zhejiang, China (mainland).
Yongming YuDepartment of Anorectal Surgery, Ningbo Second Hospital, Ningbo, Zhejiang, China (mainland).
Yisheng CaoDepartment of Anorectal Surgery, Ningbo Second Hospital, Ningbo, Zhejiang, China (mainland).
Zhenfang KongDepartment of Anorectal Surgery, Ningbo Second Hospital, Ningbo, Zhejiang, China (mainland).
Baofeng ZhouDepartment of Anorectal Surgery, Ningbo Second Hospital, Ningbo, Zhejiang, China (mainland).
Yidong XuDepartment of Anorectal Surgery, Ningbo Second Hospital, Ningbo, Zhejiang, China (mainland).
Tong YangDepartment of Anorectal Surgery, Ningbo Second Hospital, Ningbo, Zhejiang, China (mainland).
Keqiang LiClinical Research Center, Ningbo Second Hospital, Ningbo, Zhejiang, China (mainland).
Ningbo No. 2 Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Tectonic family member 1 (TCTN1), a member of the tectonic family, is involved in several developmental processes and is aberrantly expressed in multiple solid tumors. However, the expression and regulation of TCTN1 in human colorectal cancer (CRC) is still not clear. MATERIAL AND METHODS The expression of TCTN1 mRNA was first explored by using Oncomine microarray datasets. TCTN1 expression was silenced in human CRC cell lines HCT116 and SW1116 via RNA interference (RNAi). Furthermore, we investigated the effect of TCTN1 depletion on CRC cell growth by MTT, colony formation, and flow cytometry in vitro. RESULTS In this study, meta-analysis showed that the expressions of TCTN1 mRNA in CRC specimens were significantly higher than that in normal specimens. Knockdown of TCTN1 expression potently inhibited the abilities of cell proliferation and colony formation as determined. Flow cytometry analysis showed that depletion of TCTN1 could cause cell cycle arrest at the G2/M phase. In addition, Annexin V/7-AAD double-staining indicated that TCTN1 silencing promoted cell apoptosis through down-regulation of caspase 3 and Bcl-2 and upregulation of cleaved caspase 3 and PARP. CONCLUSIONS Our results indicate that TCTN1 may be crucial for CRC cell growth, providing a novel alternative to target therapies of CRC. Further research on this topic is warranted.

Indexed as

ApoptosisCaspase 3Cell CycleCell Cycle CheckpointsCell ProliferationColorectal NeoplasmsGene Expression Regulation, NeoplasticGene Knockdown TechniquesHCT116 CellsHEK293 CellsHumansMembrane ProteinsRNA, MessengerRNA, Small InterferingTransfectionCaspase 3Membrane ProteinsRNA, MessengerRNA, Small InterferingTctn1 protein, human

Identifiers

PMID28123172
PMCPMC5291083
OpenAlexW2580631883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.